All COVID-19 articles
-
NewsMount Sinai creates first manual for treating infection-associated chronic illness for clinicians
Mount Sinai has launched the country’s first clinical manual for treating infection-associated chronic illnesses (IACIs). This comprehensive guide, prepared by the Cohen Center for Recovery From Complex Chronic Illnesses, part of the Department of Rehabilitation and Human Performance, will help clinicians better diagnose and care for patients with conditions such ...
-
NewsBroad COVID-19 vaccination makes economic sense, especially for older adults, study finds
Vaccinating every person over 65 would actually save the U.S. money, while vaccinating all younger adults would be a reasonable investment, according to a new study.
-
NewsStudy: Long COVID remains a substantial financial and medical burden
Individuals with long COVID-19 experienced worse financial and employment outcomes – lasting up to three years after their initial infection. Notably, vaccination against COVID-19 was associated with strikingly improved work and financial outcomes.
-
NewsWhat exactly is Long COVID? It depends who you ask
New research finds that the definition of Long COVID varies so widely across published studies that the percentage of people identified as having the condition can differ dramatically, making it harder to treat patients and advance research.
-
NewsResearchers identify a potential biomarker for long COVID
Researchers have identified a potential biomarker for long COVID. The study results detail the detection of SARS-CoV-2 protein fragments within extracellular vesicles (EVs) — tiny, naturally occurring packages that help cells share proteins, metabolites, and other materials.
-
NewsGlobal Virus Network reaffirms support for mRNA vaccines and collaborative vaccine research
The Global Virus Network (GVN) has announced that it is unequivocally committed to the continued development and deployment of mRNA vaccines and the global scientific collaboration that makes such innovation possible.
-
NewsLab-made sugar-coated particle blocks Covid-19 infection — Possible new treatment on the horizon
Groundbreaking research has revealed a synthetic glycosystem — a sugar-coated polymer nanoparticle — that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.
-
NewsScientists develop new approach to fighting many viruses at once
Scientists have developed a research pipeline to fuel the development of “universal vaccines,” that would address broad viral families and mutated viral variants.
-
NewsRNA immunity: A silent defender against viruses in mammals
Researchers propose that small RNA molecules play a direct and specific role in fighting viral infections in mammals. RNA immunity relies on the base-pairing precision of small RNA fragments, such as microRNAs, to recognize and suppress viral genetic material.
-
NewsQ&A: Why do symptoms linger in some people after an infection?
A new review highlights that long COVID and ME/CFS share many of the same biological problems such as inflammation in the brain, issues with how cells produce energy, and problems with the immune system.
-
NewsClinical trial finds safe, effective treatment for children with severe post-Covid syndrome
Researchers have discovered that a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID. A small, randomized clinical trialfound the oral drug larazotide was both safe and effective in treating children with MIS-C.
-
NewsMucosal vaccine shows transient action against Covid-19 variant
Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings, a new study reveals.
-
NewsStudies confirm influence of country of origin on trust in COVID-19 vaccines
During the pandemic, a preference for domestic vaccines or those from countries such as the United States, Germany, and the United Kingdom was observed for the first time. This phenomenon is known in marketing as the country of origin effect.
-
NewsEconomically disadvantaged patients at greater risk for long COVID
A study found that people with social risk factors including economic instability and food insecurity at the time of COVID-19 infection were at greater risk for long COVID.
-
NewsGut microbiome may predict “invisible” chronic fatigue syndrome and long COVID
Millions suffering from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may be closer to personalized care, according to new research that shows how the disease disrupts interactions between the microbiome, immune system, and metabolism.
-
NewsScientists uncover critical role of membrane protein topology in beta-coronaviruses assembly
Beta-coronaviruses, including SARS-CoV-2, have caused global health problems. How the virus infects host cells and triggers immunological responses has been investigated extensively. However, how the virus replicates and assembles in the cell is largely unknown. Researchers at the Institute of Biophysics, Chinese Academy of Sciences, have uncovered a conserved mechanism ...
-
NewsVitamin D deficiency increases risk of COVID-19 hospitalization
Experts say it’s not just booster shots that could offer protection against Covid-19 – healthy levels of vitamin D may also play a role. Researchers found a clear link between low vitamin D levels and an increased risk of being hospitalised by the virus.
-
NewsData-driven detection of concerning SARS-CoV-2 variants months in advance
The CoVerage web platform for genomic surveillance of the SARS-CoV-2 virus enables a rapid, computational identification and characterization of potential Variants of Interest (pVOIs), with a lead time of almost three months before their WHO designation as a VOC.
-
NewsFirst global-to-local study reveals stark health inequalities from COVID-19 in 2020–2021
An international research team has conducted the first comprehensive global-to-local assessment of the direct health burden of COVID-19, spanning 920 locations worldwide and revealing pronounced and widespread disparities in COVID-19 outcomes across and within areas.
-
NewsOmicron strain BA.2.86 emergence ‘defies natural explanation’
A researcher investigating the origin of the BA.2.86 lineage found that sporadic cases were identified in multiple, geographically distant locations around the world during its initial appearance in the summer of 2023.